Citation Tools

Download PDFPDF

2022-RA-948-ESGO Neoadjuvant Chemotherapy (NACT) and Interval Debulking Surgery (IDS) in a Group of Patients with Advanced Stage Epithelial Ovarian Cancer, Unsuitable for Upfront Surgery
Free

Download to a citation manager

Cite this article as:
Siddiqua A, Sharmin F, Hossain S, et al
2022-RA-948-ESGO Neoadjuvant Chemotherapy (NACT) and Interval Debulking Surgery (IDS) in a Group of Patients with Advanced Stage Epithelial Ovarian Cancer, Unsuitable for Upfront Surgery